Improving Clinical Decision Making with Engaging CME, Tools, & Resources
Personalized Patient-Centered Glaucoma Management
Inder Paul Singh
Lorraine M. Provencher, MD
Zarmeena Vendal, MD
Manjool Shah, MD
Emily Schehlein, MD
Swarup Swaminathan, MD
SLT as First-Line Therapy
Beyond IOP: Integrating Ocular Surface Resilience Into Glaucoma Management
Walter O. Whitley, OD, FAAO
Nate Lighthizer, OD, FAAO, FAAOMS
Jessica Steen, OD, FAAO, Dipl-ABO
Trends in PDR Treatments
Maria H. Berrocal, MD
Katharine Talcott, MD
Logistical Considerations with Anti-VEGF Treatment in Wet AMD
International Congress of Scleral Contacts (ICSC) 2026
June 05, 2026
San Diego, California
GLP-1 Use and AMD Risk
Barton Lynn Blackorby, MD
Hong-Uyen Hua, MD
MH Risk Factors After RRD Repair
Avni P. Finn, MD, MBA
Sustained-Release Drug Delivery for Early-Stage Glaucoma
Zarmeena Vendal
Racial/Ethnic Disparities in TDR, DME, and Other Vision Threats in Patients With DR
Jordan Deaner
Vaidehi S. Dedania, MD
Rehan M. Hussain, MD
Modernizing Diagnosis in Early-Stage Glaucoma
Time to Recurrence and Early Risk Indicators in BRVO-Related Macular Edema
Outcomes for PDR Patients LTFU for at Least 1 Year
Kyle Davis Kovacs, MD
Matt Starr, MD
Nita Valikodath, MD, MS
Real-World Switching to Faricimab from Legacy Anti-VEGFs in Wet AMD
Lejla Vajzovic, MD, FASRS
Overcoming Cultural and Communication Disconnects, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
David Chin Yee, MD, FASRS
Suprachoroidal Steroids in Patients With a History of Glaucoma and Ocular Hypertension
Danny Mammo, MD
Loading...
We're glad to see you're enjoying Eye Health Academy… but how about a more personalized experience?
Press cancel to remain on Eye Health Academy. Press the link below or the continue button to keep going.